Solid Biosciences (SLDB) Operating Expenses (2017 - 2024)
Solid Biosciences (SLDB) has disclosed Operating Expenses for 8 consecutive years, with $39.9 million as the latest value for Q4 2024.
- Quarterly Operating Expenses rose 79.19% to $39.9 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $129.7 million through Dec 2024, up 24.44% year-over-year, with the annual reading at $179.2 million for FY2025, 38.14% up from the prior year.
- Operating Expenses hit $39.9 million in Q4 2024 for Solid Biosciences, up from $35.2 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $39.9 million in Q4 2024 to a low of $19.0 million in Q2 2020.
- Historically, Operating Expenses has averaged $26.1 million across 5 years, with a median of $25.0 million in 2023.
- Biggest five-year swings in Operating Expenses: crashed 35.59% in 2023 and later soared 79.19% in 2024.
- Year by year, Operating Expenses stood at $21.3 million in 2020, then increased by 2.15% to $21.8 million in 2021, then skyrocketed by 58.52% to $34.6 million in 2022, then plummeted by 35.59% to $22.3 million in 2023, then skyrocketed by 79.19% to $39.9 million in 2024.
- Business Quant data shows Operating Expenses for SLDB at $39.9 million in Q4 2024, $35.2 million in Q3 2024, and $27.8 million in Q2 2024.